Scinovex
article Open AccessTop 10% cited

BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus

Lara D. Veeken · 2005 · Vol. 44(7) · pp. 902–906

Abstract

Some significant changes in the BILAG disease activity index to assess patients with SLE are proposed. The process of demonstrating validity and reliability has started with these two exercises assessing real patients. Further validation studies are under way. BILAG 2004 is likely to be valuable in clinical trials assessing new therapies for the treatment of SLE, as it provides a more comprehensive system-based disease activity measure than has been available previously.

Systemic Lupus Erythematosus ResearchAtherosclerosis and Cardiovascular DiseasesCytokine Signaling Pathways and InteractionsMedicineIntraclass correlationSystemic lupus erythematosusPhysical therapyClinical trialLupus erythematosusInternal medicineDiseaseMucocutaneous zoneImmunology

MeSH terms

AdultFemaleHumansLupus Erythematosus, SystemicMaleSeverity of Illness IndexReproducibility of ResultsObserver Variation
Citations
621
FWCI
4.13
field-weighted impact
References
9
Percentile
94%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus · Scinovex